<DOC>
	<DOCNO>NCT00213733</DOCNO>
	<brief_summary>This prospective study surgically resect sample lymph node lung cancer patient . For histopathologically positive lymph node complete resection , investigator would like analyse tumor tissue allelotyping compare result observe primary lung tumor establish cartography molecular alteration resect lung cancer . For non histopathologically positive lymph node , investigator would like research presence ( ) micrometastasis allele-specific PCR ( polymerase chain reaction ) .</brief_summary>
	<brief_title>Molecular Assessment Lymph Nodes Patients With Resected ( Stage I IIIA ) Non-small Cell Lung Cancer</brief_title>
	<detailed_description>Genetic : It prospective study two year three year follow-up . No control group recruit .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Patients resectable nonsmall cell lung cancer ( stage I IIIA ) , complete resection tumor pair lymph node . Informed consent require . Another cancer Chemotherapy surgical treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Lung cancer patient</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>molecular marker</keyword>
	<keyword>lymph node complete resected</keyword>
	<keyword>Lung cancer sample pair lymph node resect</keyword>
</DOC>